Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2.
about
Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominanceSustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more.Achieving Sustained Virological Response in Hepatitis C Reduces the Long-Term Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis Employing Relative and Absolute Outcome Measures.Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis.Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye.The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience.
P2860
Q26777659-CE6E80A9-58B4-4747-B6FA-703F98991BCDQ34172595-47C198CC-B3AE-4D60-9E80-ADE24A3FBA38Q34497272-1CB8DCB7-D6D6-48F1-A082-A82CAEAEAC02Q35662485-EDD9D68B-622E-422D-A042-534D4D169AA0Q36334385-8BADAEC2-AC9D-4BD3-ADF2-FAD50B8E406FQ38522791-89B1988F-DC9F-4EC3-B422-7313797FBAA3Q40201286-F9AA7C33-0B27-464E-A65F-D590F893281E
P2860
Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Efficacy and anticarcinogenic ...... low viral load or genotype 2.
@en
Efficacy and anticarcinogenic ...... low viral load or genotype 2.
@nl
type
label
Efficacy and anticarcinogenic ...... low viral load or genotype 2.
@en
Efficacy and anticarcinogenic ...... low viral load or genotype 2.
@nl
prefLabel
Efficacy and anticarcinogenic ...... low viral load or genotype 2.
@en
Efficacy and anticarcinogenic ...... low viral load or genotype 2.
@nl
P2093
P2860
P1433
P1476
Efficacy and anticarcinogenic ...... low viral load or genotype 2.
@en
P2093
Eiko Hasegawa
Fumitaka Suzuki
Hiromi Yatsuji
Hiromitsu Kumada
Hitomi Sezaki
Kenji Ikeda
Masahiro Kobayashi
Norio Akuta
Tetsuya Hosaka
Yasuji Arase
P2860
P304
P356
10.1111/J.1872-034X.2007.00140.X
P577
2007-06-25T00:00:00Z